AMA
Kozłowska-Geller M, Głuszek S, Lewitowicz P. Five-year follow-up study of stage I-IV rectal cancer
including EGFR immunoexpression
and p21 immunoactivity. Gastroenterology Review/Przegląd Gastroenterologiczny. 2021;16(4):330-338. doi:10.5114/pg.2021.104980.
APA
Kozłowska-Geller, M., Głuszek, S., & Lewitowicz, P. (2021). Five-year follow-up study of stage I-IV rectal cancer
including EGFR immunoexpression
and p21 immunoactivity. Gastroenterology Review/Przegląd Gastroenterologiczny, 16(4), 330-338. https://doi.org/10.5114/pg.2021.104980
Chicago
Kozłowska-Geller, Monika, Stanisław Głuszek, and Piotr Lewitowicz. 2021. "Five-year follow-up study of stage I-IV rectal cancer
including EGFR immunoexpression
and p21 immunoactivity". Gastroenterology Review/Przegląd Gastroenterologiczny 16 (4): 330-338. doi:10.5114/pg.2021.104980.
Harvard
Kozłowska-Geller, M., Głuszek, S., and Lewitowicz, P. (2021). Five-year follow-up study of stage I-IV rectal cancer
including EGFR immunoexpression
and p21 immunoactivity. Gastroenterology Review/Przegląd Gastroenterologiczny, 16(4), pp.330-338. https://doi.org/10.5114/pg.2021.104980
MLA
Kozłowska-Geller, Monika et al. "Five-year follow-up study of stage I-IV rectal cancer
including EGFR immunoexpression
and p21 immunoactivity." Gastroenterology Review/Przegląd Gastroenterologiczny, vol. 16, no. 4, 2021, pp. 330-338. doi:10.5114/pg.2021.104980.
Vancouver
Kozłowska-Geller M, Głuszek S, Lewitowicz P. Five-year follow-up study of stage I-IV rectal cancer
including EGFR immunoexpression
and p21 immunoactivity. Gastroenterology Review/Przegląd Gastroenterologiczny. 2021;16(4):330-338. doi:10.5114/pg.2021.104980.